Roche's Coactin
Executive Summary
FDA announced in June 21 Federal Regiter that the regulatory review period for the antibiotic is 2,690 days. Of this time, the agency said 1,957 days occurred during the testing phase and 733 days during the approval phase. An application for Coactin (aminocillin) was filed in December 1982 and approved in December 1984.